Literature DB >> 7693383

Subsets of CD8+, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses.

E C Wang1, J Taylor-Wiedeman, P Perera, J Fisher, L K Borysiewicz.   

Abstract

Two different subsets of CD8+, CD57+ cells have been defined, one expressing high levels (CD8high+(CD57+)), the other expressing low levels of surface CD8 (CD8low+(CD57+)). Increased numbers of CD8high+(CD57+) cells correlated with previous HCMV infection. By three-colour fluorescence analysis, the CD8high+(CD57+) population expressed T cell markers such as CD3 and CD5, and most were alpha beta T cell receptor (alpha beta TCR)-positive. A significant proportion also expressed CD71 (transferrin receptor) and MHC class I, although little if any CD25 (IL-2R-p55). Some (> or = 40%) co-expressed CD45RA and CD45RO. The CD8low+(CD57+) population expressed classical natural killer (NK) cell markers--CD2, CD16 and CD56. The two subsets were also functionally distinct; CD8high+(CD57+) cells suppressed pokeweed mitogen (PWM)-driven, but not phytohaemagglutinin (PHA)-driven proliferation and immunoglobulin production; CD8low+(CD57+) cells exhibited NK cytotoxic activity which was not increased by interferon-alpha (IFN-alpha). Supernatant from cultured CD8high+(CD57+) cells suppressed PWM-driven immunoglobulin production, but not proliferation, and this effect was abrogated by physical separation with tissue culture inserts. Thus, a T cell subset expressing activation and memory T cell markers with direct non-specific suppressor activity was present in peripheral blood mononuclear cells (PBMC) of healthy subjects with asymptomatic HCMV infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693383      PMCID: PMC1534246          DOI: 10.1111/j.1365-2249.1993.tb03447.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.

Authors:  L K Borysiewicz; B Rodgers; S Morris; S Graham; J G Sissons
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

2.  Neural cell adhesion molecules and myelin-associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1.

Authors:  J Kruse; R Mailhammer; H Wernecke; A Faissner; I Sommer; C Goridis; M Schachner
Journal:  Nature       Date:  1984 Sep 13-19       Impact factor: 49.962

3.  A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).

Authors:  T Abo; C M Balch
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

4.  The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation.

Authors:  A M Würsch; J W Gratama; J M Middeldorp; C Nissen; A Gratwohl; B Speck; J Jansen; J D'Amaro; T H The; G C De Gast
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

5.  Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.

Authors:  S P James; L M Neckers; A S Graeff; J Cossman; C M Balch; W Strober
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

6.  Morphologic and phenotypic features of the subpopulation of Leu-2+ cells that suppresses B cell differentiation.

Authors:  L T Clement; C E Grossi; G L Gartland
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

7.  Human lymphocyte subpopulations identified by using three-color immunofluorescence and flow cytometry analysis: correlation of Leu-2, Leu-3, Leu-7, Leu-8, and Leu-11 cell surface antigen expression.

Authors:  L L Lanier; M R Loken
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

8.  Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.

Authors:  L L Lanier; A M Le; J H Phillips; N L Warner; G F Babcock
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

9.  HNK-1+ (Leu-7) and other lymphocyte subsets in long-term survivors with renal allotransplants.

Authors:  I Fregona; R D Guttmann; R Jean
Journal:  Transplantation       Date:  1985-01       Impact factor: 4.939

10.  Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content.

Authors:  T Cotner; J M Williams; L Christenson; H M Shapiro; T B Strom; J Strominger
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  29 in total

1.  Investigation of alpha nascent polypeptide-associated complex functions in a human CD8(+) T cell ex vivo expansion model using antisense oligonucleotides.

Authors:  N Al-Shanti; C G Steward; R J Garland; A W Rowbottom
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

2.  Abnormal T cell receptor V gene usage in myasthenia gravis: prevalence and characterization of expanded T cell populations.

Authors:  B Y Xu; R Giscombe; A Söderlund; M Troye-Blomberg; R Pirskanen; A K Lefvert
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

Review 3.  CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.

Authors:  Marius Strioga; Vita Pasukoniene; Dainius Characiejus
Journal:  Immunology       Date:  2011-06-29       Impact factor: 7.397

4.  Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging.

Authors:  S E McNerlan; I M Rea; H D Alexander; T C Morris
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

5.  Differential usage of T-cell receptor V beta gene families by CD4+ and CD8+ T cells in patients with CD8hi common variable immunodeficiency: evidence of a post-thymic effect.

Authors:  R Duchmann; J Jaffe; R Ehrhardt; D W Alling; W Strober
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

6.  T cell repertoire remodeling following post-transplant T cell therapy coincides with clinical response.

Authors:  Corey Smith; Dillon Corvino; Leone Beagley; Sweera Rehan; Michelle A Neller; Pauline Crooks; Katherine K Matthews; Matthew Solomon; Laetitia Le Texier; Scott Campbell; Ross S Francis; Daniel Chambers; Rajiv Khanna
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

7.  Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes.

Authors:  Lorraine Yeo; Alyssa Woodwyk; Sanjana Sood; Anna Lorenc; Martin Eichmann; Irma Pujol-Autonell; Rosella Melchiotti; Ania Skowera; Efthymios Fidanis; Garry M Dolton; Katie Tungatt; Andrew K Sewell; Susanne Heck; Alka Saxena; Craig A Beam; Mark Peakman
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

8.  The small heat shock protein 27 is a key regulator of CD8+ CD57+ lymphocyte survival.

Authors:  Karen L Wood; Oliver H Voss; Qin Huang; Arti Parihar; Neeraj Mehta; Sanjay Batra; Andrea I Doseff
Journal:  J Immunol       Date:  2010-04-12       Impact factor: 5.422

9.  Depression in caregivers of demented patients is associated with altered immunity: impaired proliferative capacity, increased CD8+, and a decline in lymphocytes with surface signal transduction molecules (CD38+) and a cytotoxicity marker (CD56+ CD8+).

Authors:  S Castle; S Wilkins; E Heck; K Tanzy; J Fahey
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

10.  Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer.

Authors:  T Okada; T Iiai; Y Kawachi; T Moroda; Y Takii; K Hatakeyama; T Abo
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.